Сосудистые осложнения у пациентов с сахарным диабетом 2 типа и артериальной гипертензией: факторы риска и профилактика
Аннотация
Сахарный диабет 2 типа и артериальная гипертензия у пациентов представляют серьезную проблему для современной медицины. В статье рассматриваются патогенез, клинические особенности и осложнения этих сопутствующих заболеваний. Сочетание сахарного диабета 2 типа и артериальной гипертензии приводит к ускоренному развитию микро- и макрососудистых осложнений. Длительное повышение артериального давления способствует диабетогенному эффекту и увеличивает риск сосудистых осложнений. Основные признаки — чувствительность к соли, альбуминурия, изолированная систолическая гипертензия и ортостатическая гипотензия — еще больше осложняют ситуацию. Авторы обсуждают результаты последних исследований по профилактике и лечению этих осложнений, подчеркивая важность поддержания артериального давления на целевом уровне и применения индивидуального терапевтического подхода. Контроль обмена веществ и изменение образа жизни предоставляют дополнительные возможности для профилактики. В заключение следует отметить, что для профилактики осложнений у пациентов с сахарным диабетом 2 типа и артериальной гипертензией необходим системный и комплексный подход.
Об авторах
Список литературы
Updated European Guidelines for the Management of Cardiovascular Diseases in Diabetes Mellitus (2023): Perspective of Russian Experts, Published by the Cardiology Development Support Foundation, Volume 11, Issue 40, December 2023, International Heart and Vascular Disease Journal. [in Russian].
Nelson A.J., Peterson E.D., Pagidipati N.J., Atherosclerotic cardiovascular disease and heart failure: determinants of risk and outcomes in patients with diabetes. Progr Cardiovasc Dis. 2019;62:306–314. DOI:10.1016/j.pcad.2019.07.00
Roth G.A., Mensah G.A., Johnson C.O., Addolorato G., Ammirati E., Baddour L.M., GBD-NHLBI- JACC Global Burden of Cardiovascular Diseases Writing Group. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update from the GBD 2019 Study. J. Am. Coll. Cardiol. 2020;76(25):2982–3021. DOI: 10.1016/j. jacc.2020.11.010.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19•1 million participants. Lancet. 2017;389(10064):37–55. DOI: 10.1016/S0140-6736(16)31919-5.
Emdin C.A., Anderson S.G., Woodward M., Rahimi K., Usual Blood Pressure and Risk of New-Onset Diabetes: Evidence from 4.1 Million Adults and a Meta-Analysis of Prospective Studies. J. Am. Coll. Cardiol. 2015;66(14):1552–1562. DOI: 10.1016/j.jacc.2015.07.059.
Holtrop J., Spiering W., Nathoe H.M., De Borst G.J., Kappelle L.J., De Valk H.W., Apparent therapy- resistant hypertension as risk factor for the development of type 2 diabetes mellitus. J. Hypertens. 2020;38(1):45–51. DOI: 10.1097/HJH.0000000000002227.
Brands M.W. Role of insulin-mediated antinatriuresis in sodium homeostasis and hypertension. Hypertension. 2018;72(6):1255–1262. DOI: 10.1161/HYPERTENSIONAHA.118.11728.
Solini A., Zoppini G., Orsi E., Fondelli C., Trevisan R., Vedovato M., Resistant hypertension in patients with type 2 diabetes: Clinical correlates and association with complications. J. Hypertens. 2014;32(12):2401–2410. DOI: 10.1097/HJH.0000000000000350.
Wang Q., Ma W., Xia J., Li M., Fan Y., Impact of pulse pressure on left ventricular geometry and function in elderly type 2 diabetic patients. Chinese Journal of Medical Imaging Technology. 2018;34(1):43–46. DOI: 10.13929/j.1003-3289.201703102.
Prenner S.B., Chirinos J.A., Arterial stiffness in diabetes mellitus. Atherosclerosis. 2015;238(2):370–379. DOI: 10.1016/j.atherosclerosis.2014.12.023.
Abrignani M.G., Physical exercise and risk of arterial hypertension and diabetes mellitus. Let’s move, it is never too late. Eur J Prev Cardiol.2018; 25(10): 1063-1064. doi: 10.1177/2047487318781116.
Filimonova A.S., Rasova S.A., Sopenko I.V., Arterial Hypertension and Related Factors in Patients with Type 2 Diabetes Mellitus. Actual Scientific Research in the Modern World. 2021; No. 12-1(80): 143–148. [in Russian].
Smulyan H., Lieber A., Safar M.E. Hypertension, Diabetes Type II, and Their Association: Role of Arterial Stiffness. Am J Hypertens. 2016; 29(1): 5-13. doi: 10.1093/ajh/hpv107.
Rishko O.A., Derbak M.A., Ihnatko Y.Y., The clinical experience of the effective use of dapagliflozin in comorbid cardiac patients with concomitant type 2 diabetes mellitus and arterial hypertension on the background of overweight in outpatient setting. Wiad Lek. 2022; 75(10): 2397-2401. doi: 10.36740/WLek202210114.
Berra C., Manfrini R., Regazzoli D., Blood pressure control in type 2 diabetes mellitus with arterial hypertension. The important ancillary role of SGLT2-inhibitors and GLP1-receptor agonists. Pharmacol Res. 2020; 160: 105052. doi: 10.1016/j.phrs.2020.105052.
Chahoud J., Mrad J., Semaan A., Prevalence of diabetes mellitus among patients with essential arterial hypertension. J Med Liban. 2015;63(2):74-80. doi: 10.12816/0012554.
Chernatska O., Demikhova N., Improvement of treatment in persons with arterial hypertension and type 2 diabetes mellitus. Georgian Med News. 2018; (284): 47-51.
Optimization of the Treatment of Hypertension in Patients with Diabetes Mellitus. System Analysis and Management in Biomedical Systems. 2020; Vol. 19, No. 4: 37–41. DOI: 10.36622/VSTU.2020.19.4.005.[in Russian]
Iadecola C., Gottesman R.F., Neurovascular and ognitive dysfunction in hypertension. Circ. Res. 2019;124(7):1025–1044. DOI: 10.1161/CIRCRESAHA.118.313260.
Steffen P.L.S., Mendonça C.S., Meyer E., Motivational Interviewing in the Management of Type 2 Diabetes Mellitus and Arterial Hypertension in Primary Health Care: An RCT. Am J Prev Med. 2021 May; 60(5): e203-e212. doi: 10.1016/j.amepre.2020.12.015.
ElSayed N.A., Aleppo G., Aroda V.R., Standards of Care in Diabetes—2023. Diabets Care. 2023; 46(S1): 1-291. doi: https://diabetesjournals.org/care/issue/46/Supplement_1
Draznin B., Aroda V.R., Bakris G., 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022 American Diabetes Association Professional Practice Committee. 2022; 45(Suppl 1): 144-174. doi: 10.2337/dc22-S010.
de Lira C.A.B., Viana R.B., Luz N.F., Analysis of type 2 diabetes mellitus and arterial hypertension content in exercise physiology textbooks. Adv Physiol Educ. 2019; 43(3): 253-258. doi: 10.1152/advan.00043.2019.
Comini L.O., de Oliveira L.C., Borges L.D., Prevalence of chronic kidney disease in Brazilians with arterial hypertension and/or diabetes mellitus. J Clin Hypertens (Greenwich). 2020 Sep; 22(9): 1666-1673. doi: 10.1111/jch.13980.
Huang D, Refaat M, Mohammedi K., Macrovascular Complications in Patients with Diabetes and Prediabetes. Biomed Res Int. 2017:7839101. doi:10.1155/2017/7839101.
Cui J, Liu Y, Li Y., Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective. Front Cardiovasc Med. 2021;8:644189. doi:10.3389/fcvm.2021.644189.
Nowbar AN, Gitto M, Howard JP, Mortality From Ischemic Heart Disease. Circ Cardiovasc Qual Outcomes. 2019;12(6):e005375. doi:10.1161/CIRCOUTCOMES.118.005375.
Jensen LO, Maeng M, Thayssen P, Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2012;109(5):629-35. doi:10.1016/j.amjcard.2011.10.018.
Ceriello A., Hyperglycemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes. Eur J Cardiovasc Prev Rehabil. 2010 May;17(1):S15–9.
Duckworth W, Abraira C, Moritz T, VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129.
Istamova S.S., LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN COMORBID CONDITION //Euro-Asia Conferences. – 2021. – . 1. –
№. 1. – . 334-338
de Boer IH, et al. Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med. 2008 Sep 22;168(17):1867–73.
ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New Engl J Med. 2008;358:2560.
Tashkenbaeva E.N., Associated Risk Factors of Cardiovascular Events in Postmenopausal Women. Cardio. 2020; Vol. 1, No. 3. [in Russian].
Center for Disease Control of Prevention. SEARCH for Diabetes in Youth. [accessed November 13, 2010]. Available at: http://www.cdc.gov/diabetes/pubs/factsheets/search.htm#3.
Ceriello A, Ihnat MA, Thorpe JE. The ‘metabolic memory’: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab. 2009;94:410–415.
Ayerden EF, et al. The relationship between vascular endothelial growth factor (VEGF) and microalbuminuria in patients with essential hypertension. Intern Med. 2008;47(17):1511–6.
Saran R., Robinson B., Abbott K.C., Agodoa L.Y.C., Bragg-Gresham J., Balkrishnan R., US Renal Data System 2018 Annual Data Report: Epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 2019;73(3 Suppl 1):A7–A8. DOI: 10.1053/j.ajkd.2019.01.001
Viazzi F., Piscitelli P., Ceriello A., Fioretto P., Giorda C., Guida P., Resistant hypertension, time-updated blood pressure values and renal outcome in type 2 diabetes mellitus. J. Am. Heart Assoc. 2017;6:e006745. DOI: 10.1161/JAHA.117.006745.
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.